Filing Flows › Comparisons › RMTI vs FHTX
Rockwell Medical vs Foghorn Therapeutics: RMTI and FHTX compared
Rockwell Medical is the larger company: $17.8M of revenue in its latest quarter (Q2 2026) against $16.1M for Foghorn Therapeutics (Q2 2026). Foghorn Therapeutics is growing faster (+113% against +11% a year earlier). Rockwell Medical is more profitable, with an operating margin of -6.0% against -54.8%.
Where the money goes: RMTI and FHTX
Rockwell Medical (RMTI) · Q2 2026
Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%, net loss $1.2M, operating cash flow $2.1M. The chart follows the revenue to costs, profit and cash.
Foghorn Therapeutics (FHTX) · Q2 2026
Foghorn Therapeutics, Q2 2026: revenue $16.1M (+113% year over year), operating margin -54.8%, net loss $7.2M, operating cash flow −$17.8M. The chart follows the revenue to costs, profit and cash.
| Rockwell Medical (RMTI) | Foghorn Therapeutics (FHTX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $17.8M | $16.1M |
| Revenue growth, Y/Y | +11% | +113% |
| Operating margin | -6.0% | -54.8% |
| Net earnings | −$1.2M | −$7.2M |
| Net margin | -6.6% | -44.7% |
| Operating cash flow | $2.1M | −$17.8M |
| Free cash flow | $1.5M | — |
| Market value | — | $132M |
| Analysts’ mean target | — | $4.17 |
Questions
Which is bigger, Rockwell Medical or Foghorn Therapeutics?
Rockwell Medical is the larger company: $17.8M of revenue in its latest quarter (Q2 2026) against $16.1M for Foghorn Therapeutics (Q2 2026).
Is Rockwell Medical or Foghorn Therapeutics growing faster?
Foghorn Therapeutics is growing faster (+113% against +11% a year earlier).
Which is more profitable, Rockwell Medical or Foghorn Therapeutics?
Rockwell Medical is more profitable, with an operating margin of -6.0% against -54.8%.
More: Rockwell Medical earnings · how Rockwell Medical makes money · Foghorn Therapeutics earnings · how Foghorn Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 6, 2026). Fiscal quarters can end on different dates. Not investment advice.